AstraZeneca Pharma India (BOM:506820) Long-Term Capital Lease Obligation : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India Long-Term Capital Lease Obligation?

AstraZeneca Pharma India's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil.

AstraZeneca Pharma India's quarterly Long-Term Capital Lease Obligation increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹133 Mil) but then declined from Sep. 2024 (₹133 Mil) to Dec. 2024 (₹0 Mil).

AstraZeneca Pharma India's annual Long-Term Capital Lease Obligation declined from Mar. 2022 (₹50 Mil) to Mar. 2023 (₹37 Mil) and declined from Mar. 2023 (₹37 Mil) to Mar. 2024 (₹28 Mil).

AstraZeneca Pharma India Long-Term Capital Lease Obligation Historical Data

The historical data trend for AstraZeneca Pharma India's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India Long-Term Capital Lease Obligation Chart

AstraZeneca Pharma India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

93.00

86.30

50.20

36.90

27.80

AstraZeneca Pharma India Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	27.80	-	133.30	-

AstraZeneca Pharma India (BOM:506820) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

AstraZeneca Pharma India Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Pharma India Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (BOM:506820) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

ASTRAZEN:India

Address

Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045

Website

https://www.astrazeneca.com

AstraZeneca Pharma India Ltd is engaged in the manufacture, trading, and marketing of pharmaceutical products. Its only operating segment is Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of its revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation, Autoimmunity, Neuroscience Infection and Vaccines.

AstraZeneca Pharma India Headlines

No Headlines